Analyzing single-cell RNA sequencing (scRNA-seq) data is crucial for understanding complex biological processes and disease ...

MultiKano is the first automatic cell type annotation method tailored to single-cell multi-omics data. MultiKano introduces a novel data augmentation strategy based on paired scRNA-seq and scATAC-seq ...

Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are ...

In June, Google DeepMind took the wraps off AlphaGenome, its latest machine learning model for biological discovery. While ...

Scientists at ETH Zurich have broken new ground by generating over 400 types of nerve cells from stem cells in the lab, far surpassing previous efforts that produced only a few dozen. By ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach requires chronic suppression of the immune system to prevent rejection of donor cells. A Vertex Pharmaceuticals ...

Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

The last time I wrote an article on Sana Biotechnology (NASDAQ:SANA) it was with respect to an article entitled "Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus". It is still set to ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...